check_circleStudy Completed

Arterial hypertension

Survey to assess why people are not responding to treatment in Hypertension

Trial purpose

This study will describe the factors influencing the physician in face of elevated blood pressure in already treated patients

Key Participants Requirements

Sex

Both

Age

18 - N/A

Trial summary

Enrollment Goal
1589
Trial Dates
November 2009 - February 2012
Phase
N/A
Could I Receive a placebo
No
Products
Kinzal/Pritor (Telmisartan, BAY68-9291)
Accepts Healthy Volunteer
No

Where to participate

StatusInstitutionLocation
Completed
Many Locations, France

Primary Outcome

  • Percentage of patients, according to the level of cardiovascular risk, who, at the end of the visit:- do not present any modification of hypertension treatment (therapeutic inertia) - present a change in the hypertension therapeutic
    date_rangeTime Frame:
    on day 1
    enhanced_encryption
    Safety Issue:
    No

Secondary Outcome

  • Analyses of the factors that had an impact on the therapeutic decision
    date_rangeTime Frame:
    on day 1
    enhanced_encryption
    Safety Issue:
    No

Trial design

Observational Survey Assessing the Factors of Treatment Intensification in Uncontrolled Hypertensive Patients Under a Combination Therapy, Either Fixed or not, of a Renin-Angiotensin System Blocker (RASB) and Hydrochlorothiazide (HCTZ), According to Their Level of Cardiovascular Risk.
Trial Type
Observational
Intervention Type
Drug
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A